Management of the axillary nodes

Breast Cancer

Volumn 6, Issue 1, 1999, Pages 1-12

  Morrow, Monica ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Axillary metastases; Sentinel node; Staging

Indexed keywords

EID: 33748367233     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966900     Document Type: Review

References (103)

1. Halsted WS: A clinical and histological study of certain adenocarcinomata of the breast. Ann Surg 28:557-576, 1898.
2. Halsted WS: The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46:1-19, 1907.
3. Turner-Warwick R: The lymphatics of the breast. Br J Surg 46:574-582, 1959.
4. Veronesi U, Valagussa P: Inefficacy of internal mammary node dissection in breast cancer surgery. Cancer 47:170-175, 1981. (Pubitemid 11167377)
5. Rosen PP, Lesser ML, Kinne DW et al: Discontinuous or "skip" metastases in breast carcinoma; Analysis of 1228 axillary dissections. Ann Surg 197:276-283, 1983. (Pubitemid 13159264)
6. Veronesi U, Rilke F, Luini A, et al: Distribution of nodal metastases by level of invasion. Cancer 59:682-687, 1987.
7. Danforth DN Jr, Findlay PA, McDonald HD, et al: Complete axillary lymph node dissection for Stage I-II carcinoma of the breast. J Clin Oncol 4:655-662, 1985.
8. Pigott J, Nicholas R, Maddox WA, et al: Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 158:255-259, 1984. (Pubitemid 14161079)
9. Smith J, Gomez-Araujo J, Gallager H, et al: Carcinoma of the breast; Analysis of total lymph node involvement versus level of metastasis. Cancer 39:527-532, 1997.
10. Chevinsky A, Ferrara J, James A, et al: Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast. Surgery 108:612-618, 1990. (Pubitemid 20330297)
11. Boova R, Bonanni R, Rosato F: Patterns of axillary nodal involvement in breast cancer. Ann Surg 196:642-646, 1982.
12. Haagensen C: The surgical treatment of mammary carcinoma. In: Diseases of the Breast, 2nd ed, WB Saunders, Philadelphia, pp704-709, 1971.
13. Fisher B, Redmond C, Fisher ER, et al: Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with and without irradiation. N Engl J Med 312:674-681, 1985. (Pubitemid 15134703)
14. Renolleau C, Merviel P, Clough KB, et al: Isolated axillary recurrences after conservative treatment of breast cancer. Eur J Cancer 32 A: 617-621, 1996.
15. Halverson KJ, Taylor ME, Perez CA, et al: Regional nodal management and patterns of failure following conservative surgery and radiation therapy for Stage I and II breast cancer. Int J Radiat Oncol Biol Phys 26:593-599, 1993. (Pubitemid 23220155)
16. Steele RJ, Forrest AP, Gibson T, et al: The effect of lower axillary sampling in obtaining lymph node status in breast cancer; A controlled randomized trial. Br J Surg 72:368-369, 1985. (Pubitemid 15034708)
17. Forrest A, Stewart H, Roberts M, et al: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196:371-377, 1982.
18. Kissin MW, Price AB, Thompson EM, et al: The inadequacy of axillary sampling in breast cancer. Lancet 1:1210-1212, 1982.
19. Graverson MP, Blichert-Toft B, Andersen JA, et al: Breast cancer; Risk of axillary recurrence in node negative patients following partial dissection of the axilla. Eur J Surg Oncol 14:407-412, 1988. (Pubitemid 18263429)
20. Fowble B, Solin LJ, Schultz D, et al: Frequency, site of relapse, and outcome of regional node failures following surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 17:703-710, 1989. (Pubitemid 19250521)
21. National Institutes of Health Consensus Conference: Treatment of early stage breast cancer. JAMA 265:391-395, 1991.
22. Ivens D, Moe AL, Podd TJ, et al: Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136-138, 1992.
23. Tasmuth T, von Smitten K, Kalso E: Pain and other symptoms during the first year after radical and conservative therapy for breast cancer. Br J Cancer 74:2024-2031, 1996. (Pubitemid 27007153)
24. Lin PP, Alison DC, Wainstock J, et al: Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 11:1536-1544, 1993. (Pubitemid 23228260)
25. Hladuik M, Huchcroft S, Temple W, et al: Arm function after axillary dissection for breast cancer. A pilot study to provide parameter estimates. J Surg Oncol 50:47-52, 1992.
26. Keramopoulos A, Tsionou C, Minaretzis D, et al: Arm morbidity following treatment of breast cancer with total axillary dissection; A multivariated approach. Oncology 50:445-449, 1993. (Pubitemid 23323714)
27. Wood K: Intercostobrachial nerve entrapment syndrome. South Med J 71:662-663, 1978. (Pubitemid 8369385)
28. Britton RC, Nelson PA: Cause and treatment of postmastectomy lymphedema of the arm; Report of 114 cases. JAMA 180:95-102, 1962.
29. Hughes JH, Patel AR: Swelling of the arm following radical mastectomy. Br J Surg 53:4-14, 1966.
30. Werner R, McCormick B, Petrek J, et al: Arm edema in conservatively managed breast cancer; Obesity is a major predictive factor. Radiology 180:177-184, 1991.
31. Kiel KD, Rademacker AW: Early stage breast cancer; Arm edema after wide excision and breast irradiation. Radiology 198:279-283, 1996. (Pubitemid 26009708)
32. Bau AB, Waters R, Fish S, et al: Radical axillary dissection in the staging and treatment of breast cancer. Ann Royal Coll Surg Engl 74:126-129, 1992.
33. Liljegren G, Uolonberg L, and the Uppsala-Örebro Breast Cancer Study Group: Arm morbidity after sector resection and axillary dissection with and without postoperative radiotherapy in breast cancer stage I; Results from a randomized trial. Eur J Cancer 33:193-199, 1997.
34. Pezner RD, Patterson MP, Hill LR, et al: Arm lymphedema in patients treated conservatively for breast cancer; Relationship to age and axillary node dissection technique. Int J Radiat Oncol Biol Phys 12:2079-2083, 1986. (Pubitemid 17215521)
35. Fisher B, Wolmark N, Bauer M, et al: The accuracy of clinical node staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765-771, 1981.
36. Haagensen CD: Clinical classification and choice of treatment. In: Diseases of the Breast, 3rd ed, WB Saunders, Philadelphia, pp 617-668, 1986.
37. Dershaw DD, Panicek DM, Osborne MP: Significance of lymph nodes visualized by the mammographic axillary view. Breast Dis 4:271-280, 1991.
38. March DE, Wechsler RJ, Kurtz AB, et al: CT-pathology correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr 15:440-444, 1991.
39. Venta L: Evaluation of axillary node status with imaging modalities. Semin Breast Dis. In press.
40. Weiner JI, Chako AC, Merten CW, et al: Breast and axillary tissue MR imaging; Correlation of signal intensities and relaxation time with pathologic findings. Radiology 160:229-305, 1986.
41. Fossel ET, Brodsky G, De Layre JL, et al: Nuclear magnetic resonance imaging for the differentiation of benign and malignant breast tissue and axillary lymph nodes. Awn Surg 198:541-544, 1983.
42. Mussurakis S, Buckley DL, Horsman A: Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 203:317-321, 1997. (Pubitemid 27176198)
43. Avril N, Dose J, Janicke F, et al: Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(Fluorine-18) flouro-2-deoxy-D-glucose. J Natl Cancer Inst 88:1204-1209, 1996. (Pubitemid 26302033)
44. Adler LP, Faulhaber PF, Schnur KC, et al: Axillary lymph node metastases; Screening with [F-18] 2-deoxy-2-fluoro-d-glucose (FDG) PET. Radiology 203:323-327, 1997. (Pubitemid 27176199)
45. Chu KC, Tarone RE, Kessler LG, et al: Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88:1571-1579, 1996. (Pubitemid 26374510)
46. Cady B: Case against axillary lymphadenectomy for most patients with infiltrating breast carcinoma. J Surg Oncol 66:7-10, 1997. (Pubitemid 27381472)
47. 1a breast carcinoma; Is it indicated? Cancer 73:664-667, 1994. (Pubitemid 24046609)
48. 1 breast carcinoma. Cancer 79:1856-1864, 1997. (Pubitemid 27200366)
49. Nemoto T, Vans J, Bedwani RN, et al: Management and survival of female breast cancer; Results of a national survey by the American College of Surgeons. Cancer 45:2917-2924, 1980. (Pubitemid 11191732)
50. Ravdin PM, De Laurentis M, Vendely T, et al: Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 86:1771-1775, 1994. (Pubitemid 24373452)
51. 1a breast cancer. Am J Surg 172:501-505, 1996. (Pubitemid 26415760)
52. Reger V, Beito G, Jolly PC: Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 157:501-502, 1989. (Pubitemid 19127468)
53. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187, 1989. (Pubitemid 19032001)
54. Halverson KJ, Perez CA, Myerson R, et al: Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 417:461-466, 1994. (Pubitemid 24379345)
55. Holland PA, Walls J, Boggis C R M, et al: A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds. Br J Cancer 74:1643-1646, 1996. (Pubitemid 26386095)
56. Seidman JD, Schnaper LA, Aisner SC: Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis. Cancer 75:65-71, 1995.
57. Brenin DR, Morrow M: Is AJCC staging for breast cancer accurate for patients undergoing re-excision for positive margins? J Surg Oncol 5:719-723, 1998. (Pubitemid 28565724)
58. Chadha M, Chabon AB, Friedmann P, et al: Predictors of axillary lymph node metastases in patients with T1 breast cancer; A multivariate analysis. Cancer 73:350-353, 1994. (Pubitemid 24030613)
59. Wong J, Kopald K, Morton D: The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125:1298-1302, 1990. (Pubitemid 20360789)
60. Solin L, Fowble B, Yeh IT, et al: Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23:961-968, 1992.
61. Frazier T, Copeland E, Gallagher M, et al: Prognosis and treatment in minimal breast cancer. Am J Surg 133:697-701, 1977. (Pubitemid 8116180)
62. Nevin J, Pinzon G, Morton T, et al: Minimal breast cancer. Am J Surg 139:357-359, 1980.
63. McDivitt R, Boyce W, Gersell D: Tubular carcinoma of the breast; Clinical and pathological observations concerning 135 cases. Am J Surg Pathol 6:401-411, 1982. (Pubitemid 12044738)
64. Peters G, Wolff M, Haagensen C: Tubular carcinoma of the breast; Clinical-pathologic correlations based on 100 cases. Ann Surg 193:138-149, 1981. (Pubitemid 11153094)
65. Schuh ME, Nemoto T, Penetrante RB, et al: Intraductal carcinoma; Analysis of presentation, pathologic findings and outcome of disease. Arch Surg 121:1303-1307, 1986.
66. Kinne DW, Petrek JA, Osborne MP, et al: Breast carcinoma in situ. Arch Surg 124:33-36, 1989. (Pubitemid 19025899)
67. Fisher B: The evolution of paradigms for the management of breast cancer; A personal perspective. Cancer Res 52:2371-2376, 1992.
68. Adair F, Berg J, Joubert L, et al: Long term follow up of breast cancer patients; The 30 year report. Cancer 33:1145-1150, 1974.
69. Brinkley D, Haybittle JL: The curability of breast cancer. Lancet 2:95-97, 1975.
70. 0) breast carcinoma. J Clin Oncol 7:355-366, 1989. (Pubitemid 19075017)
71. Hayward JL: The Guy's trial of treatment of early breast cancer. World J Surg 1:314-316, 1998.
72. Hayward J, Caleffi M: The significance of local control in the primary treatment of breast cancer. Arch Surg 122:1244-1248, 1987.
73. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949-955, 1997. (Pubitemid 27425950)
74. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997. (Pubitemid 27425951)
75. Cabanes PA, Salmon RJ, Vilcoq JR, et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339:1245-1248, 1992.
76. Morton DC, Duan-Ren W, Wong JH: Technical details of intraoperative lymphatic mapping and sentinel node biopsy in the management of primary melanoma. Arch Surg 127:392-399, 1992.
77. Krag DN, Weaver OJ, Alex JC, et al: Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993. (Pubitemid 24019852)
78. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994. (Pubitemid 24313232)
79. Giuliano AE, Jones RC, Brennan M, et al: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350, 1997. (Pubitemid 27251137)
80. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996. (Pubitemid 26406231)
81. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864-1867, 1997. (Pubitemid 27270119)
82. Shons A, Joseph E, Cox CE, et al: Predictors of sentinel lymph node metastases in the lymphatic mapping of breast cancer patients. Breast Cancer Res Treat 46:24, 1997.
83. Galimberti V, Zurrida S, Verones P, et al: Can sentinel lymph node biopsy avoid axillary dissection in No breast cancer patients? Breast Cancer Res Treat 46:24, 1997.
84. Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3:336-340, 1997.
85. Borgstein PJ, Pijpers R, Cormans EF, et al: Sentinel lymph node biopsy in breast cancer; Guidelines and pitfalls on lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275-283, 1998. (Pubitemid 28124433)
86. Kag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer; A multicenter validation study. N Engl J Med 337:941-946, 1998. (Pubitemid 28455095)
87. Morrow M, Foster RS: Staging of breast cancer; A new rationale for internal mammary node biopsy. Arch Surg 116:748-751, 1981. (Pubitemid 11107339)
88. Valagussa P, Bonnadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy; Analysis of 716 consecutive patients. Cancer 41:1170-1177, 1978.
89. Saphir O, Amromin GD: Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1:238-241, 1948.
90. Fisher ER, Swamidoss S, Lee CH, et al: Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 42:2025-2031, 1978. (Pubitemid 9055971)
91. Pickren JW: Significance of occult metastases; A study of breast cancer. Cancer 14:1266-1271, 1961.
92. Hainsworth PJ, Tjandra JJ, Stillwell RG: Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80:459-463, 1993. (Pubitemid 23116083)
93. Trojani M, de Mascarel I, Bonichon F, et al: Micrometastases to axillary lymph nodes from carcinoma of breast; Detection by immunohistochemistry and prognostic significance. Br J Cancer 55:303-306, 1987. (Pubitemid 17036845)
94. Trojani M, de Mascarel I, Coindre J, et al: Micrometastases to axillary nodes from invasive lobular carcinoma of the breast; Detection by immunohistochemistry and prognostic significance. Br J Cancer 56:838-839, 1987. (Pubitemid 18048364)
95. McGuckin MA, Cummings MC, Walsh MD, et al: Occult axillary lymph node metastases in breast cancer; Their detection and prognostic significance. Br J Cancer 73:88-95, 1996. (Pubitemid 26026266)
96. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 335:1565-1568, 1990.
97. de Mascarel I, Bonichon F, Coindre JM, et al: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques; Reevaluation with longer follow up. Br J Cancer 66:523-527, 1992.
98. Turner RR, Oilila DW, Krasne DL, et al: Histopathologic validation of the sentinel node hypothesis for breast carcinoma. Ann Surg 226:271-278, 1997. (Pubitemid 28070919)
99. Hartveit F, Lilleng PK: Breast cancer; Two micrometastatic variants in the axilla that differ in prognoses. Histopathology 28:241-246, 1996.
100. Mori M, Mimori K, Inoue M, et al: Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 55:3417-3420, 1995.
101. Schoenfeld A, Lugmani Y, Sinnett MD, et al: Keratin 19mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients. Br J Cancer 74:1639-1642, 1996. (Pubitemid 26386094)
102. Cox CE, Haddad F, Cox JM, et al: Lymphatic mapping in the treatment of breast cancer. Oncology 12:1283, 1998.
103. Morrow M, Bethke K, Talamonti M, et al: Intraoperative lymphatic mapping and sentinel node biopsy; Re-sults of a randomized trial comparing blue dye to blue dye plus radioactivity. Submitted for publication.